Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
Provided By GlobeNewswire
Last update: Jun 13, 2025
HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of its executive leadership team will attend and participate in the 2025 BIO International Convention, taking place June 16-19, 2025, in Boston, Massachusetts.
Read more at globenewswire.comNASDAQ:PCSA (8/14/2025, 12:52:40 PM)
0.2222
-0.01 (-2.54%)
Find more stocks in the Stock Screener
